Colin G. Sandercock
General Counsel
Cue Biopharma, Inc. (CUE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Colin G. Sandercock
Colin G. Sandercock is recorded as General Counsel at Cue Biopharma, Inc. (CUE). The proxy statement of Cue Biopharma, Inc. reports total compensation of $599,222 for Colin G. Sandercock in fiscal 2025, including a base salary of $448,646. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cue Biopharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Daniel R. Passeri CEO, Board Member
- Dr. Shao-Lee Lin CEO, Board Member
- Lucinda Warren CEO, CFO
- Usman Azam CEO, Board Member
- James Ahlers CFO
- Kerri Millar CFO
- Sumita Ray General Counsel
- Michael Meluzio Chief Accounting Officer
- Daniel Camardo Board Member
- Jill Broadfoot Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cue Biopharma, Inc. (CUE) | SVP, General Counsel and Secretary | $448,646 | $599,222 |
| 2019 | Cue Biopharma, Inc. (CUE) | Senior Vice President, General Counsel and Secretary | $285,000 | $625,514 |
| 2018 | Cue Biopharma, Inc. (CUE) | Senior Vice President, General Counsel and Secretary | $275,000 | $330,220 |
Recent activity
No call appearances or filed executive changes recorded yet.